MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2022.1012827

Медицинская библиотека · Frontiers in medicine · 2022

Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2.

Casanova Nancy G, Reyes-Hernon Vivian, Gregory Taylor, Sun Belinda, Bermudez Tadeo, Hufford Matthew K, Oita Radu C, Camp Sara M, Hernandez-Molina Gabriela, Serrano Jorge Rojas, Sun Xiaoguang, Fimbres Jocelyn, Mirsaeidi Mehdi, Sammani Saad, Bime Christian, Garcia Joe G N

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Progressive pulmonary fibrosis is a serious complication in subjects with sarcoidosis. The absence of reliable, non-invasive biomarkers that detect early progression exacerbates the difficulty in predicting sarcoidosis severity. To potentially address this unmet need, we evaluated a panel of markers for an association with sarcoidosis progression (HBEGF, NAMPT, IL1-RA, IL-6, IL-8, ANG-2). This panel encompasses proteins related to inflammation, vascular injury, cell proliferation, and fibroblast mitogenesis processes.

METHODS

Plasma biomarker levels and biomarker protein expression in lung and lymph nodes tissues (immunohistochemical studies) from sarcoidosis subjects with limited disease and progressive (complicated) sarcoidosis were performed. Gene expression of the protein-coding genes included in this panel was analyzed using RNAseq in sarcoidosis granulomatous tissues from lung and lymph nodes.

RESULTS

Except for IL-8, plasma levels of each biomarker-eNAMPT, IL-1RA, IL-6, ANG-2, and HBEGF-were significantly elevated in sarcoidosis subjects compared to controls. In addition, plasma levels of HBEGF were elevated in complicated sarcoidosis, while eNAMPT and ANG-2 were observed to serve as markers of lung fibrosis in a subgroup of complicated sarcoidosis. Genomic studies corroborated HBEGF and NAMPT among the top dysregulated genes and identified cytokine-related and fibrotic pathways in lung granulomatous tissues from sarcoidosis.

CONCLUSION

These findings suggest HBEGF, eNAMPT, and ANG-2 may serve as potential novel indicators of the clinical severity of sarcoidosis disease.

Для цитирования: Casanova Nancy G, Reyes-Hernon Vivian, Gregory Taylor, Sun Belinda, Bermudez Tadeo, Hufford Matthew K, Oita Radu C, Camp Sara M, Hernandez-Molina Gabriela, Serrano Jorge Rojas, Sun Xiaoguang, Fimbres Jocelyn, Mirsaeidi Mehdi, Sammani Saad, Bime Christian, Garcia Joe G N. Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2.. Frontiers in medicine. 2022. DOI: 10.3389/fmed.2022.1012827.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.